Clinical Trials in Nashville

Showing 16081-16100 of 20,298 trials

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867

Objectives: * To present the rates of adverse reactions after a dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine. * To present immunogenicity before and after a single dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine.

DiphtheriaTetanusPertussis+2 more

Sanofi Pasteur, a Sanofi Company989 participantsStarted Feb 2004

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Oakland, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

NCT01011049

The purpose of this study is to generate additional data on the immunogenicity and safety of revaccination with Fluzone Intradermal (ID) or Fluzone Intramuscular (IM) vaccine. Primary Objective: * To evaluate and describe the safety profile of revaccination with Fluzone ID for all participants. Secondary Objective: * To describe immunogenicity following revaccination with Fluzone ID or Fluzone IM.

Influenza

Sanofi Pasteur, a Sanofi Company1,250 participantsStarted Sep 2009

Hoover, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +42 more locations

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

Find Trials by Condition in Nashville

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Validation of TearLab Osmometer - Human Factor Usability Report

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Dose Comparison Study of Menactra® in US Children

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Health-related Quality of Life Measure in Pediatric Lupus

Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease

Water-aided Colonoscopy vs Air Insufflation Colonoscopy in Colorectal Cancer Screening